Organon B V

Type: Company
Name: Organon B V
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

The Total Transparency Manifesto: Not So Fast

In 1993, TAP Pharmaceuticals paid me $900 to give a visiting Grand Rounds lecture at the Robert Wood Johnson Medical Center in New Jersey. I was a new attending physician at nearby Saint Barnabas, just starting my reproductive endocrinology practice. ... [Published Forbes.com - Sep 22 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

Shortage of bladder cancer drug could be tragic for patients, doctor says

, EDT.TORONTO - Bladder Cancer Canada says it is deeply concerned about the shortage of a drug critical to treating the common malignancy, which will be diagnosed in about 8,000 Canadians this year.The shortage of the medication — called bacillus Calmette-Guerin, ... [Published CJAD 800 - Sep 08 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

Investigators at University Medical Center Report Findings in Diabetes (Excess mortality in mothers of patients with polycystic ovary syndrome)

By a News Reporter-Staff News Editor at Diabetes Week Researchers detail new data in Diabetes. According to news originating from Utrecht, Netherlands, by NewsRx correspondents, research stated, "Do diabetic parents of patients with polycystic ovary ... [Published Pharmacy Choice - Sep 08 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer

/PRNewswire/ --~ Clinical and Business Development expert re-joins the Company ~Kiadis Pharma B.V. ("Kiadis Pharma", "Kiadis" or "the Company"), a clinical stage biopharmaceutical company developing T-cell immunotherapy treatments for blood cancers, today ... [Published WGNT - Sep 03 2014]
First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

Minority squeeze-out | impact of the Companies Act 2013

Whilst the concept of squeezing-out minority shareholders has always existed in India (though not tested), it has been explicitly introduced in the new Companies Act, 2013 (“2013 Act”). India is in the process of adopting the 2013 Act, which is set to ... [Published Lexology - Sep 01 2014]
First reported Aug 23 2014 - Updated Aug 23 2014 - 1 reports

The Male Contraceptive Pill

Share on TwitterPage 1 of 2Would you be willing to pop a pill that brings your sperm count down to zero? Or do you feel that, beyond condoms, birth control is mainly a woman's responsibility? A 1997 survey by the Henry J. Kaiser Family Foundation, an ... [Published AskMen US - Aug 23 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 2 reports

Arch Biopartners appoints Haigh to board

Mr. Adrian Haigh reportsARCH BIOPARTNERS APPOINTS ADRIAN HAIGH TO BOARD OF DIRECTORSArch Biopartners Inc. has appointed Adrian Haigh as an interim director.Mr. Haigh is currently senior vice-president, commercial operations, and chief operating officer ... [Published Stockwatch - Aug 21 2014]
First reported Aug 09 2014 - Updated Aug 09 2014 - 1 reports

CCI imposes Rs.1.41 cr penalty on chemist association Ferozepur for anti-competitive practices

The Competition Commission of India (CCI) has imposed a fine of Rs. 1.41 crore against Chemists and Druggists Association, Ferozepur (CDAF), Punjab alleging inter alia contravention of the provisions of sections 3 and 4 of the Competition Act. As per ... [Published PharmaBiz - Aug 09 2014]
First reported Apr 29 2014 - Updated Apr 29 2014 - 1 reports

Delisting prop for Fulford

Mumbai, April 28: Shares of Fulford (India) Ltd — a domestic subsidiary of pharmaceutical giant Merck & Co — today surged 20 per cent to hit the upper circuit after its board approved a delisting offer by the parent company. On the Bombay Stock Exchange, ... [Published Calcutta Telegraph - Apr 29 2014]

Quotes

"And that's a big deal. Losing a bladder is a pretty life-altering experience. And if that could not be prevented, that would be a real shame."
According to the news editors, the research concluded: "These companies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."
" I am extremely excited to have the opportunity to rejoin Kiadis Pharma and be able to focus on its T-cell based immunotherapy product ATIR ™"
TORONTO ONTARIO--(Marketwired - Aug 21, 2014) - Arch Biopartners Inc ("Arch" or the "Company) (CSE:ACH)(OTCBB:FOIFF) announced today the board has appointed Adrian Haigh as an interim director."

More Content

All (19) | News (13) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (4) | Press Releases (0)
sort by: Date | Relevance
The Total Transparency Manifesto: Not So Fast [Published Forbes.com - Sep 22 2014]
Shortage of bladder cancer drug could be tragic... [Published CJAD 800 - Sep 08 2014]
Investigators at University Medical Center Repo... [Published Pharmacy Choice - Sep 08 2014]
Kiadis Pharma Appoints Jeroen Rovers as its Chi... [Published WGNT - Sep 03 2014]
Minority squeeze-out | impact of the Companies ... [Published Lexology - Sep 01 2014]
The Male Contraceptive Pill [Published AskMen US - Aug 23 2014]
Arch Biopartners appoints Haigh to board [Published Stockwatch - Aug 21 2014]
Arch Biopartners Appoints Adrian Haigh to Board... [Published Scottrade - Aug 21 2014]
CCI imposes Rs.1.41 cr penalty on chemist assoc... [Published PharmaBiz - Aug 09 2014]
Delisting prop for Fulford [Published Calcutta Telegraph - Apr 29 2014]
BioProcess International: Lean Six Sigma [Published Future of BioPharma - Feb 17 2014]
NuvaRing® Lawsuit Update: $100 Million Settleme... [Published PRWeb - Feb 09 2014]
Merck Agrees To Pay $100 Million To Settle Nuva... [Published The Consumerist - Feb 07 2014]
NuvaRing Lawsuit and Settlement Update from the... [Published PRWeb - Jan 15 2014]
Baron & Budd Now Accepting NuvaRing Lawsuits [Published PRWeb - Dec 20 2013]
Biography for Maricke Padt [Published Able2Act - Oct 16 2007]
Biography for Eric Nunes [Published Able2Act - Oct 16 2007]
Biography for Kees Deijl [Published Able2Act - Oct 16 2007]
Biography for Claudia Cuca [Published Able2Act - Oct 16 2007]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BioProcess International: Lean Six Sigma [Published Future of BioPharma - Feb 17 2014]
Our author from today's excerpt is Dr. Stephen C. Taylor, Vice President, Fujifilm Diosynth Biotechnologies  About 10 years ago as a vice president of Avecia Biologics, I wrote an article for an early issue of BioProcess International looking ahead ...
Merck Agrees To Pay $100 Million To Settle Nuva... [Published The Consumerist - Feb 07 2014]
There are thousands of pending lawsuits against big pharma biggie Merck involving its NuvaRing birth control product and whether its marketing downplayed the risk of blood clots to women who use it. Today, Merck announced that it’s agreed to pay out ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.